Key result
A review of 74 epidemiological papers on combined oral contraceptives and cardiovascular disease found only 5 papers directly addressed the clinical risk in healthy, non-smoking women under 35.
Why the study?
What is the risk of cardiovascular disease among users of currently available, low dose, combined oral contraceptives who are aged less than 35 years, do not smoke, and do not have a medical condition known to increase the risk of vascular disease?
What is the risk of cardiovascular disease among users of currently available, low dose, combined oral contraceptives who are aged less than 35 years, do not smoke, and do not have a medical condition known to increase the risk of vascular disease?
Answers are grounded in this paper and cite their sources.
Most published epidemiological studies on oral contraceptives and cardiovascular risk fail to provide data in a format useful for answering specific clinical questions for low-risk patients.
OBJECTIVE: To explore the usefulness of epidemiological data to guide clinical practice by seeking an answer to the question "What is the risk of cardiovascular disease among users of currently available, low dose, combined oral contraceptives who are aged less than 35 years, do not smoke, and do not have a medical condition known to increase the risk of vascular disease?" DESIGN: Review of all relevant published studies identified from the library of references held by Royal College of General Practitioners' Manchester Research Unit, checking of reference lists of identified studies, and Medline search. MAIN OUTCOME MEASURES: Identification of methodologically sound studies able to address the specific clinical question. RESULTS: Our literature search identified 74 papers about the relation between current use of combined oral contraceptives and cardiovascular disease: 23 papers reporting risk of venous thromboembolism, 22 on ischaemic stroke, 13 on haemorrhagic stroke or subarachnoid haemorrhage, 13 on all stroke, and 33 on myocardial infarction. Only five papers provided information that directly addressed our clinical question; all related to the risk of venous thromboembolism. Fourteen of the discarded papers probably had the potential to answer our clinical question. CONCLUSIONS: Much of the epidemiological data about the risk of cardiovascular disease in users of combined oral contraceptives is not useful to clinicians. Some of the discarded data could be made more useful to clinicians by reanalysis. This situation is unlikely to be unique to use of contraceptives.
No takes yet. Share an insight, caveat, or question.
Hannaford et al. (1998) conducted a review in cardiovascular disease. low dose, combined oral contraceptives was evaluated on Identification of methodologically sound studies able to address the specific clinical question. A review of 74 epidemiological papers on combined oral contraceptives and cardiovascular disease found only 5 papers directly addressed the clinical risk in healthy, non-smoking women under 35.
Synapse has enriched 10 related papers. Consider them for comparative context: